Drug Pricing Insurance Coverage and Processing Pharmaceutical Companies 
Express Pharma
SEPTEMBER 6, 2023
To help financially weak citizens gain access to affordable healthcare, the Pradhan Mantri Jan Arogya Yojana (PMJAY) was launched in 2018, providing about 500 million Indians with a ₹5 lakh family health insurance cover that include coverage for 1,400 medical procedures as well as critical diseases like prostate cancer.
Pharma Marketing Network
FEBRUARY 5, 2025
The real challenge lies in ensuring it reaches the right patients at the right time and at an affordable price. This is where pharmaceutical market access comes into play. Pharmaceutical market access refers to the process of ensuring a drug is not only approved but also commercially viable, reimbursed, and accessible to patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
FEBRUARY 7, 2023
Launching a new drug can be a risky business, with regulatory approval no guarantee that private, commercial, and government-funded insurers will reimburse it. In Europe, the pricing and reimbursement (P&R) of pharmaceuticals is governed by individual member states.
STAT
MARCH 26, 2024
Novo Nordisk plans to seek coverage by Germany’s public health insurance scheme for the use of its Wegovy drug to cut the risk of strokes and heart attacks, if the extended indication wins European approval , Reuters notes. Meanwhile, the Biosecure Act, designed to reduce U.S.
Proxsys Rx
AUGUST 16, 2023
“Don’t believe drug companies: 340B is a program worth saving” On Tuesday, August 8, The Hill published a guest editorial (title above) by John Hassell — national director of advocacy at the AIDS Healthcare Foundation (AHF). First, start with presenting drug company-funded research as if it is non-biased. margins vs. 7.7%
Expert insights. Personalized for you.
59 
Let's personalize your content